S-adenosylmethionine enhances anti-PD-1 efficacy in uveal melanoma by targeting EZH2
{{output}}
Objective: To investigate the effect of S-adenosylmethionine (SAM) on enhancing anti-programmed death 1 (PD-1) therapy in uveal melanoma (UM) by targeting Enhancer of Zeste homolog 2 (EZH2). The synergistic effect of SAM in combi... ...
